Isolated systolic hypertension: Pressure on the anaesthetist?

Anaesthesia

Volumn 56, Issue 6, 2001, Pages 505-510

  Prys Roberts, C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DILEVALOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; EPHEDRINE; EPROSARTAN; IMIDAZOLINE DERIVATIVE; IRBESARTAN; LOSARTAN; METHOXAMINE; MONATEPIL; MOXONIDINE; RAMIPRIL; TELMISARTAN; VALSARTAN;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANESTHESIST; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; EDITORIAL; ELDERLY CARE; GOOD CLINICAL PRACTICE; HUMAN; PATIENT CARE; POPULATION RISK; PRACTICE GUIDELINE; RISK ASSESSMENT; SYSTOLIC HYPERTENSION; TREATMENT PLANNING; VASCULAR DISEASE;

AGED; ALGORITHMS; ANESTHESIA; ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; SYSTOLE;

EID: 0034986448     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2001.02136.x     Document Type: Editorial

References (59)

1. Causes de l'hypertension arterielle
2. Un sfigmomanometro nuovo
3. Sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
4. Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients
5. Studies of anaesthesia in relation to hypertension. II. Haemodynamic consequences of induction and endotracheal intubation
6. Studies of anaesthesia in relation to hypertension. IV. The effects of artificial ventilation on the circulation and pulmonary gas exchanges
7. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade
8. Studies of anaesthesia in relation to hypertension. VI. Cardiovascular responses to epidural blockade of treated and untreated hypertensive patients
9. Risks of general anesthesia and elective operation in the hypertensive patient
10. Hypertension and anesthesia - Fifty years on
11. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study
12. Isolated systolic hypertension: Clinical significance and management
13. Isolated systolic hypertension: A radical re-think
14. Isolated systolic hypertension and anaesthesia
15. Cardiovascular monitoring in patients with vascular disease
16. Chronic antihypertensive therapy (Ch. 15)
17. Anesthesia in the aged hypertensive patient (Ch. 11)
18. Hypertension and systemic arterial disease. (Ch 2)
19. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham Study
20. Isolated systolic hypertension and mortality after age 60 years. A prospective population-based study
21. Velocity of transmission of the pulse wave and elasticity of the arteries
22. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension. Comparison between urban and rural communities in China
23. Arterial stiffness, systolic blood pressure, and logical treatment of hypertension
24. Effects of age on ventricular-vascular coupling
25. Hemodynamic patterns of age-related changes in blood pressure. The Framingham heart study
26. Pathophysiology of hypertension: Differences between young and elderly
27. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR)
28. Structural remodelling in hypertensive heart disease and the role of hormones
29. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals
30. Reversal of hypertrophy: An active biologic process
31. A randomized, placebo-controlled, double blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension
32. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
33. 1- adrenoceptor-blocking activity in experimental animals
34. 1 adrenergic-blocking activity, and nitrendipine and lipoprotein and carbohydrate metabolism in patients with hypertension
35. Role of blood pressure in the development of congestive cardiac failure
36. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP)
37. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-hypertension)
38. Syst-Eur: A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization
39. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
40. Guidelines for the management of hypertension: Report of the third working party of the BHS
41. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly?
42. 1-imidazoline agonist
43. Clinical pharmacology of doxazosin in patients with essential hypertension
44. Hypertension, antihypertensive drugs, anaesthetic management of the hypertensive patient (Ch 38)
45. Predictors of postoperative myocardial ischaemia. The role of intercurrent arterial hypertension and other risk factors
46. Predictors of post-operative myocardial ischemia in patients undergoing noncardiac surgery
47. Preoperative evaluation of the patient with cardiovascular disease - Risk assessment and outcome
48. Left ventricular hypertrophy increases the risk of postoperative myocardial ischaemia
49. Myocardial ischaemia in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic blocking agent
50. Prophylactic atenolol reduces postoperative myocardial ischemia
51. β-Adrenergic-blocking drugs. Incredibly useful, incredibly underutilized
52. Beneficial effects from β-adrenergic blockade in elderly patients undergoing noncardiac surgery
53. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting inhibitors
54. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction
55. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists
56. Should angiotensin II antagonists be discontinued before surgery?
57. Propofol-induced increase in vascular capacitance is due to inhibition of sympathetic vasoconstrictive activity
58. Prophylactic ephedrine attenuates the hemodynamic response to propofol in elderly female patients